文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

铜死亡:机制与癌症的关联。

Cuproptosis: mechanisms and links with cancers.

机构信息

Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

State Key Laboratory of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.

出版信息

Mol Cancer. 2023 Mar 7;22(1):46. doi: 10.1186/s12943-023-01732-y.


DOI:10.1186/s12943-023-01732-y
PMID:36882769
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9990368/
Abstract

Cuproptosis was a copper-dependent and unique kind of cell death that was separate from existing other forms of cell death. The last decade has witnessed a considerable increase in investigations of programmed cell death, and whether copper induced cell death was an independent form of cell death has long been argued until mechanism of cuproptosis has been revealed. After that, increasing number of researchers attempted to identify the relationship between cuproptosis and the process of cancer. Thus, in this review, we systematically detailed the systemic and cellular metabolic processes of copper and the copper-related tumor signaling pathways. Moreover, we not only focus on the discovery process of cuproptosis and its mechanism, but also outline the association between cuproptosis and cancers. Finally, we further highlight the possible therapeutic direction of employing copper ion ionophores with cuproptosis-inducing functions in combination with small molecule drugs for targeted therapy to treat specific cancers.

摘要

铜死亡是一种依赖铜的独特的细胞死亡方式,与现有的其他细胞死亡形式不同。过去十年中,对程序性细胞死亡的研究有了相当大的增加,而铜诱导的细胞死亡是否是一种独立的细胞死亡形式一直存在争议,直到铜死亡的机制被揭示。此后,越来越多的研究人员试图确定铜死亡与癌症过程之间的关系。因此,在这篇综述中,我们系统地详细介绍了铜的系统和细胞代谢过程以及与铜相关的肿瘤信号通路。此外,我们不仅关注铜死亡的发现过程及其机制,还概述了铜死亡与癌症之间的关联。最后,我们进一步强调了利用具有铜死亡诱导功能的铜离子载体与小分子药物联合进行靶向治疗以治疗特定癌症的可能治疗方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/29a2edc555e2/12943_2023_1732_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/ab2616f13646/12943_2023_1732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/2be44f37fe8b/12943_2023_1732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/ef43af160c86/12943_2023_1732_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/445539e3ec95/12943_2023_1732_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/29a2edc555e2/12943_2023_1732_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/ab2616f13646/12943_2023_1732_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/2be44f37fe8b/12943_2023_1732_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/ef43af160c86/12943_2023_1732_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/445539e3ec95/12943_2023_1732_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97ab/9990368/29a2edc555e2/12943_2023_1732_Fig5_HTML.jpg

相似文献

[1]
Cuproptosis: mechanisms and links with cancers.

Mol Cancer. 2023-3-7

[2]
Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.

Cell Commun Signal. 2024-5-1

[3]
Cuproptosis: A novel therapeutic target for overcoming cancer drug resistance.

Drug Resist Updat. 2024-1

[4]
Cuproptosis in lung cancer: therapeutic options and prognostic models.

Apoptosis. 2024-10

[5]
Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.

Biomed Pharmacother. 2024-2

[6]
Targeting cuproptosis for cancer therapy: mechanistic insights and clinical perspectives.

J Hematol Oncol. 2024-8-16

[7]
Copper homeostasis and cuproptosis in cancer immunity and therapy.

Immunol Rev. 2024-1

[8]
Cuproptosis and its application in different cancers: an overview.

Mol Cell Biochem. 2023-12

[9]
Comprehensive investigation into cuproptosis in the characterization of clinical features, molecular characteristics, and immune situations of clear cell renal cell carcinoma.

Front Immunol. 2022

[10]
Copper homeostasis and cuproptosis in mitochondria.

Life Sci. 2023-12-1

引用本文的文献

[1]
Cuproptosis-Related Gene FDX1 Induces Malignant Progression and Immune Suppression in Triple-Negative Breast Cancer.

Biochem Genet. 2025-9-5

[2]
Identification of cuproptosis-related genes in chronic apical periodontitis based on bulk and single-cell RNA sequencing analyses and experimental validation.

Front Immunol. 2025-8-20

[3]
Copper and hepatic lipid dysregulation: Mechanisms and implications.

World J Hepatol. 2025-8-27

[4]
Programmed Cell Death in Cancer.

MedComm (2020). 2025-8-31

[5]
Tumor Microenvironment Specifically Regulated Nano Chemoamplifier for Chemosensitization and Activation of Anti-Tumor Immune Response by Coordinating Intracellular Magnesium Overload.

Pharmaceutics. 2025-8-9

[6]
Exploring Cuproptosis-Related Prognostic Signature for Hepatocellular Carcinoma: Bioinformatics and In Vitro Analyses.

Dig Dis Sci. 2025-8-28

[7]
Mechanism of action of cuproptosis and prospects for anti-tumor therapy.

World J Clin Cases. 2025-8-26

[8]
Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis.

Mol Cancer. 2025-8-27

[9]
Comprehensive analysis of regulated cell death pathways: intrinsic disorder, protein-protein interactions, and cross-pathway communication.

Apoptosis. 2025-8-19

[10]
Decipherment of disulfidptosis-related mutation profile, chemosensitivity, and prognosis in diffuse large B-cell lymphoma.

J Mol Med (Berl). 2025-8-18

本文引用的文献

[1]
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.

Front Pharmacol. 2022-9-21

[2]
Signature of seven cuproptosis-related lncRNAs as a novel biomarker to predict prognosis and therapeutic response in cervical cancer.

Front Genet. 2022-9-20

[3]
Identification of cuproptosis -related subtypes, the development of a prognosis model, and characterization of tumor microenvironment infiltration in prostate cancer.

Front Immunol. 2022

[4]
Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.

Front Oncol. 2022-9-20

[5]
System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma.

J Transl Med. 2022-10-4

[6]
A cuproptosis-related lncRNA signature identified prognosis and tumour immune microenvironment in kidney renal clear cell carcinoma.

Front Mol Biosci. 2022-9-14

[7]
Comprehensive analysis of cuproptosis-related long noncoding RNA immune infiltration and prediction of prognosis in patients with bladder cancer.

Front Genet. 2022-9-14

[8]
FDX1 expression predicts favourable prognosis in clear cell renal cell carcinoma identified by bioinformatics and tissue microarray analysis.

Front Genet. 2022-9-16

[9]
Risk model of hepatocellular carcinoma based on cuproptosis-related genes.

Front Genet. 2022-9-15

[10]
Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.

Front Genet. 2022-9-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索